A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...
A new systematic review and meta-analysis suggests that nerandomilast (Jascayd; Boehringer Ingelheim), an oral therapy for ...
The study covers the period of 2015-2019 in Germany, before approvals for CAR T-cell therapy, pirtobrutinib, and the arrival ...
A decade after the CDC opioid guidelines, Michael Lynch, MD, examines misapplication, fentanyl’s role, and evolving pain ...
The study covers the period of 2015-2019, before approvals for CAR T-cell therapy, pirtobrutinib, and the arrival of covalent ...
As oral peptide therapies gain attention across metabolic health, sports performance, and longevity medicine, questions ...
Analysis of billing codes before and after implementation of a care process for weight-focused visits revealed increased ...
The big question in administration of bispecific antibodies these days is how quickly they can move to the outpatient setting ...
Recent updates to the National Comprehensive Cancer Network (NCCN) guidelines for cutaneous squamous cell carcinoma (CSCC) ...
Dermoscopy can noninvasively identify immune checkpoint inhibitor (ICI)–related skin toxicities early in patients with melanoma, guide management, and reduce the need for biopsies, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results